コロンビアの妊活年齢の女性におけるヴァルプロ酸の使用と避妊薬との併用
Jorge E Machado-Alba1, Andrés Gaviria-Mendoza1,2, Manuel E Machado-Duque1,2
1Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Risaralda, Colombia.
Pharmacoepidemiology and drug safety
|August 29, 2025
まとめ
既知のテロゲンであるバルプロ酸を使用した女性は,非常に低い避妊効果を示しました. これは,この脆弱な集団における意図しない妊娠の重大なリスクを強調しています.
科学分野:
- 薬用警戒と生殖健康
- 薬物の安全性とテロゲニシティ
- 女性の健康に関する研究
背景:
- バルプロ酸は,テロジェニック効果が知られている広く使用される薬剤です.
- 有効な避妊は,妊娠できる年齢の女性がテロゲン薬を使用する際に不可欠です.
- バルプロ酸の使用に関するこれまでのデータは限られている.
研究 の 目的:
- 妊娠可能年齢の女性の避妊薬の使用率と範囲を決定するために,バルプロ酸を処方した.
- 適切な避妊手段なしでバルプロ酸を使用している女性の妊娠の可能性を評価する.
主な方法:
- コロンビアで2022年1月から2023年12月の間,少なくとも1ヶ月間バルプロ酸を使用した女性22,855人のデータを分析した記述的研究.
- ホルモン避妊薬の投与に関するデータが収集され,分析された.
- 避妊薬の適用範囲は,女性がバルプロ酸と併用して避妊薬を使用する割合として計算された.
主要な成果:
- バルプロ酸を使用した女性の8. 0%だけが,研究期間中に避妊手段の適用を受けていた.
- 避妊薬の普及率はわずか5.3%でした.
- 平均期間は72.5日,中位は30日でした.
結論:
- バルプロ酸を使用している妊活年齢の女性の多くは,妊娠から十分な保護を受けていません.
- この避妊薬の使用不足は,予期せぬ妊娠と潜在的テロゲン性被曝の重大なリスクをもたらします.
- ヴァルプロ酸の使用者のための避妊カウンセリングとアクセスを改善するために緊急の介入が必要である.
関連する概念動画
01:22Birth Control Methods
2.3K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
2.3K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
644
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
644
01:07Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
01:22Hormonal Regulation of the Menstrual Cycle
688
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
688
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K